デフォルト表紙
市場調査レポート
商品コード
1704508

ヘマトクリット測定装置の世界市場レポート 2025年

Hematocrit Test Devices Global Market Report 2025


出版日
ページ情報
英文 200 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
ヘマトクリット測定装置の世界市場レポート 2025年
出版日: 2025年04月01日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ヘマトクリット測定装置市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.5%で63億7,000万米ドルに成長します。予測期間の成長は、貧血の有病率の増加、血液疾患の症例の増加、高齢者人口の増加、健康とフィットネスへの注目の高まり、心血管診断装置へのニーズの広がりに起因すると考えられます。予測期間における主な動向としては、最先端ソリューションの導入、医学における技術の進歩、効率的で革新的な新製品の創出、ヘマトクリット検査の技術開発、ヘルスケア分野の進歩などが挙げられます。

血液疾患の事例の増加は、今後数年間のヘマトクリット測定装置市場の拡大を促進すると予想されます。血液疾患には、赤血球、白血球、血小板、血漿など、ヒトの血液のさまざまな成分に影響を及ぼす疾患が含まれます。これらの疾患は、遺伝的要因、環境汚染、ライフスタイルの変化などの複合的な要因により、より一般的になってきています。ヘマトクリット測定装置は、全血中の赤血球の容積率を測定する上で重要な役割を果たし、患者の血液学的健康状態について不可欠な洞察を提供します。例えば、米国がん協会が2024年1月に発表した報告書では、2024年の米国における白血病の新規患者数は約6万2,770人で、推定死亡数は2万3,670人と予測されています。これらの症例のうち、急性骨髄性白血病(AML)は約20,800例が新たに発症すると予測され、主に成人患者が罹患し、AMLが原因で約1万1,220人が死亡するとされています。このように、血液疾患の増加がヘマトクリット測定装置市場の成長を刺激しています。

ヘマトクリット値検査装置市場の主要企業は、全血球算定(CBC)血液学分析装置など、血液細胞に関する定量的・定性的情報を提供する製品群を革新しています。全血球計数(CBC)血液学分析装置は、赤血球(RBC)、白血球(WBC)、血小板を含む血液の様々な成分を測定・分析するために利用される自動装置です。例えば、2022年3月、中国の医療機器会社であるMindray Medical International Limitedは、BC-700血球計数装置シリーズを発表しました。このシリーズは全血球算定(CBC)と赤血球沈降速度(ESR)検査の両方を網羅し、プレミアム製品に近い高度な診断技術で中規模検査室に対応しています。BC-720、BC-760、BC-780などのモデルを含むBC-700シリーズは、ハイエンドのBC-6000シリーズをよりコンパクトにしたもので、マインドレイのSFキューブ3D分析技術を搭載しています。SF Cubeテクノロジーは、蛍光と2角レーザー散乱信号を活用し、標的細胞の3次元解析を可能にします。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界ヘマトクリット測定装置 PESTEL分析(政治、社会、技術、環境、法的要因、促進要因と抑制要因)
  • 最終用途産業の分析
  • 世界のヘマトクリット測定装置市場:成長率分析
  • 世界のヘマトクリット測定装置市場の実績:規模と成長, 2019-2024
  • 世界のヘマトクリット測定装置市場の予測:規模と成長, 2024-2029, 2034F
  • 世界ヘマトクリット測定装置総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界のヘマトクリット測定装置市場:製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ヘマトクリット検査計
  • ヘマトクリット検査装置
  • 試薬および消耗品
  • 世界のヘマトクリット測定装置市場:用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 貧血
  • 真性多血症
  • 先天性心疾患
  • その他の用途
  • 世界のヘマトクリット測定装置市場:エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院および外来手術センター
  • クリニック
  • 診断および病理学研究室
  • その他のエンドユーザー
  • 世界のヘマトクリット測定装置市場ヘマトクリット検査計の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ハンドヘルドヘマトクリットメーター
  • ポータブルヘマトクリットメーター
  • デスクトップヘマトクリットメーター
  • ポイントオブケアヘマトクリットメーター
  • デジタルヘマトクリットメーター
  • 電池式ヘマトクリットメーター
  • 世界のヘマトクリット測定装置市場ヘマトクリット検査分析装置のサブセグメンテーション(タイプ別)、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 自動ヘマトクリット分析装置
  • ベンチトップ型ヘマトクリット分析装置
  • 半自動ヘマトクリット分析装置
  • マイクロヘマトクリット分析装置
  • ハイスループットヘマトクリット分析装置
  • コンパクトヘマトクリット分析装置
  • 世界のヘマトクリット測定装置市場試薬および消耗品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ヘマトクリット試験紙
  • ヘマトクリットピペットと毛細管
  • ヘマトクリット検査用血液サンプル採取チューブ
  • ヘマトクリット検査用品質管理試薬
  • ヘマトクリット測定装置の校正標準
  • 使い捨て検査キットおよび消耗品

第7章 地域別・国別分析

  • 世界のヘマトクリット測定装置市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界のヘマトクリット測定装置市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • ヘマトクリット測定装置市場:競合情勢
  • ヘマトクリット測定装置市場:企業プロファイル
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Danaher Corporation
  • Siemens Healthcare GmbH
  • Becton, Dickinson and Company(BD)
  • Terumo Corporation
  • Beckman Coulter Inc.
  • Mindray Medical International Limited
  • bioMerieux SA
  • Sysmex Corporation
  • Horiba Ltd.
  • Nihon Kohden Corporation
  • Erba Mannheim
  • Heska Corporation
  • EKF Diagnostics Holding Plc.
  • Nova Biomedical Corporation
  • Boule Diagnostics AB

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • ヘマトクリット測定装置市場2029:新たな機会を提供する国
  • ヘマトクリット測定装置市場2029:新たな機会を提供するセグメント
  • ヘマトクリット測定装置市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r30370

Hematocrit test devices are medical instruments utilized to measure the percentage of red blood cells (RBCs) in a person's total blood volume. These devices serve various purposes, including monitoring chronic conditions, preoperative assessments, detecting blood doping, screening blood donors, managing emergencies, and conducting research and clinical trials.

The primary types of hematocrit test devices include hematocrit test meters, hematocrit test analyzers, and reagents and consumables. A hematocrit (HCT) test meter is a point-of-care device employed to measure the percentage of red blood cells in whole blood. It finds applications in conditions such as anemia, polycythemia vera, congenital heart diseases, among others, and is utilized by various end-users, including hospitals and ambulatory surgical centers, clinics, diagnostic and pathology labs, among others.

The hematocrit test devices market research report is one of a series of new reports from The Business Research Company that provides hematocrit test devices market statistics, including hematocrit test devices industry global market size, regional shares, competitors with a hematocrit test devices market share, detailed hematocrit test devices market segments, market trends and opportunities, and any further data you may need to thrive in the hematocrit test devices industry. This hematocrit test devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hematocrit test devices market size has grown strongly in recent years. It will grow from $4.63 billion in 2024 to $4.95 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to a rise in awareness regarding anemia, lack of iron and vitamins, increased incidence of chronic illnesses, the surge in government funding, and increase in the population.

The hematocrit test devices market size is expected to see strong growth in the next few years. It will grow to $6.37 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to increasing prevalence of anemia, growing cases of blood disorders, rise in geriatric population, growth in focus on health and fitness, and widening need for cardiovascular diagnostic equipment. Major trends in the forecast period include the introduction of cutting-edge solutions, advancement of technology in medical science, creation of new efficient and innovative products, technical developments in hematocrit testing, and advancements in the healthcare sector.

The increasing instances of blood disorders are anticipated to drive the expansion of the hematocrit test devices market in the coming years. Blood disorders encompass conditions affecting the various components of human blood, such as red blood cells, white blood cells, platelets, and plasma. These disorders are becoming more prevalent due to a combination of factors including genetic factors, environmental pollution, and changes in lifestyle. Hematocrit test devices play a vital role in measuring the volume percentage of red blood cells in whole blood, offering essential insights into the patient's hematological well-being. For example, a report published by the American Cancer Society in January 2024 projects approximately 62,770 new cases of leukemia in the United States for 2024, leading to an estimated 23,670 deaths. Among these cases, around 20,800 new instances of acute myeloid leukemia (AML) are expected, predominantly affecting adults, with approximately 11,220 deaths attributed to AML, primarily occurring in adult patients. Thus, the rising occurrences of blood disorders are stimulating the growth of the hematocrit test devices market.

Leading companies in the hematocrit test device market are innovating their product offerings, such as complete blood count (CBC) hematology analyzers, to deliver both quantitative and qualitative information about blood cells. A complete blood count (CBC) hematology analyzer is an automated instrument utilized to measure and analyze various components of blood, including red blood cells (RBCs), white blood cells (WBCs), and platelets. For instance, in March 2022, Mindray Medical International Limited, a China-based medical device company, introduced the BC-700 hematology analyzer series. This series encompasses both complete blood count (CBC) and erythrocyte sedimentation rate (ESR) tests, catering to medium-volume laboratories with advanced diagnostic technologies akin to premium products. The BC-700 Series, including models such as BC-720, BC-760, and BC-780, is a more compact iteration of the high-end BC-6000 Series, featuring Mindray's SF Cube 3D analysis technology. Leveraging fluorescence and bi-angular laser scatter signals, the SF Cube technology enables three-dimensional analysis of target cells.

In June 2023, Mars Incorporated, a US-based packaged food products manufacturer, acquired Heska Corporation for $1.3 billion. With this acquisition, Heska now operates under Mars Petcare's Science & Diagnostics division, expanding its reach in diagnostics and technology. The integration facilitates accelerated research and development efforts while enhancing global access to pet healthcare solutions. Heska Corporation specializes in manufacturing hematocrit test devices.

Major companies operating in the hematocrit test devices market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare GmbH, Becton, Dickinson and Company (BD), Terumo Corporation, Beckman Coulter Inc., Mindray Medical International Limited, bioMerieux SA, Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Erba Mannheim, Heska Corporation, EKF Diagnostics Holding Plc., Nova Biomedical Corporation, Boule Diagnostics AB, Stanbio Laboratory Lp, Drucker Diagnostics, A. Menarini Diagnostics Srl, Sensa Core, Mikroscan Technologies Inc.

North America was the largest region in the hematocrit test devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hematocrit test devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hematocrit test devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hematocrit test devices market consists of sales of hematocrit centrifuges, test strips, capillary transfer tubes, and adapter kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hematocrit Test Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hematocrit test devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hematocrit test devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hematocrit test devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Hematocrit Test Meter; Hematocrit Test Analyzer; Reagents And Consumables
  • 2) By Application: Anemia; Polycythemia Vera; Congenital Heart Diseases; Other Applications
  • 3) By End-User: Hospitals And Ambulatory Surgical Centers; Clinics; Diagnostic And Pathology Labs; Other End-Users
  • Subsegments:
  • 1) By Hematocrit Test Meter: Handheld Hematocrit Meters; Portable Hematocrit Meters; Desktop Hematocrit Meters; Point-Of-Care Hematocrit Meters; Digital Hematocrit Meters; Battery-Powered Hematocrit Meters
  • 2) By Hematocrit Test Analyzer: Automated Hematocrit Analyzers; Benchtop Hematocrit Analyzers; Semi-Automated Hematocrit Analyzers; Microhematocrit Analyzers; High-Throughput Hematocrit Analyzers; Compact Hematocrit Analyzers
  • 3) By Reagents And Consumables: Hematocrit Test Strips; Hematocrit Pipettes And Capillaries; Blood Sample Collection Tubes For Hematocrit Testing; Quality Control Reagents For Hematocrit Testing; Calibration Standards For Hematocrit Devices; Disposable Test Kits And Consumables
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Bayer AG; Thermo Fisher Scientific Inc.; Abbott Laboratories
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hematocrit Test Devices Market Characteristics

3. Hematocrit Test Devices Market Trends And Strategies

4. Hematocrit Test Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Hematocrit Test Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Hematocrit Test Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Hematocrit Test Devices Market Growth Rate Analysis
  • 5.4. Global Hematocrit Test Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Hematocrit Test Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Hematocrit Test Devices Total Addressable Market (TAM)

6. Hematocrit Test Devices Market Segmentation

  • 6.1. Global Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hematocrit Test Meter
  • Hematocrit Test Analyzer
  • Reagents And Consumables
  • 6.2. Global Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Anemia
  • Polycythemia Vera
  • Congenital Heart Diseases
  • Other Applications
  • 6.3. Global Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Ambulatory Surgical Centers
  • Clinics
  • Diagnostic And Pathology Labs
  • Other End-Users
  • 6.4. Global Hematocrit Test Devices Market, Sub-Segmentation Of Hematocrit Test Meter, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Handheld Hematocrit Meters
  • Portable Hematocrit Meters
  • Desktop Hematocrit Meters
  • Point-Of-Care Hematocrit Meters
  • Digital Hematocrit Meters
  • Battery-Powered Hematocrit Meters
  • 6.5. Global Hematocrit Test Devices Market, Sub-Segmentation Of Hematocrit Test Analyzer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Automated Hematocrit Analyzers
  • Benchtop Hematocrit Analyzers
  • Semi-Automated Hematocrit Analyzers
  • Microhematocrit Analyzers
  • High-Throughput Hematocrit Analyzers
  • Compact Hematocrit Analyzers
  • 6.6. Global Hematocrit Test Devices Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hematocrit Test Strips
  • Hematocrit Pipettes And Capillaries
  • Blood Sample Collection Tubes For Hematocrit Testing
  • Quality Control Reagents For Hematocrit Testing
  • Calibration Standards For Hematocrit Devices
  • Disposable Test Kits And Consumables

7. Hematocrit Test Devices Market Regional And Country Analysis

  • 7.1. Global Hematocrit Test Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Hematocrit Test Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hematocrit Test Devices Market

  • 8.1. Asia-Pacific Hematocrit Test Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hematocrit Test Devices Market

  • 9.1. China Hematocrit Test Devices Market Overview
  • 9.2. China Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hematocrit Test Devices Market

  • 10.1. India Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hematocrit Test Devices Market

  • 11.1. Japan Hematocrit Test Devices Market Overview
  • 11.2. Japan Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hematocrit Test Devices Market

  • 12.1. Australia Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hematocrit Test Devices Market

  • 13.1. Indonesia Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hematocrit Test Devices Market

  • 14.1. South Korea Hematocrit Test Devices Market Overview
  • 14.2. South Korea Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hematocrit Test Devices Market

  • 15.1. Western Europe Hematocrit Test Devices Market Overview
  • 15.2. Western Europe Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hematocrit Test Devices Market

  • 16.1. UK Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hematocrit Test Devices Market

  • 17.1. Germany Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hematocrit Test Devices Market

  • 18.1. France Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hematocrit Test Devices Market

  • 19.1. Italy Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hematocrit Test Devices Market

  • 20.1. Spain Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hematocrit Test Devices Market

  • 21.1. Eastern Europe Hematocrit Test Devices Market Overview
  • 21.2. Eastern Europe Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hematocrit Test Devices Market

  • 22.1. Russia Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hematocrit Test Devices Market

  • 23.1. North America Hematocrit Test Devices Market Overview
  • 23.2. North America Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hematocrit Test Devices Market

  • 24.1. USA Hematocrit Test Devices Market Overview
  • 24.2. USA Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hematocrit Test Devices Market

  • 25.1. Canada Hematocrit Test Devices Market Overview
  • 25.2. Canada Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hematocrit Test Devices Market

  • 26.1. South America Hematocrit Test Devices Market Overview
  • 26.2. South America Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hematocrit Test Devices Market

  • 27.1. Brazil Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hematocrit Test Devices Market

  • 28.1. Middle East Hematocrit Test Devices Market Overview
  • 28.2. Middle East Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hematocrit Test Devices Market

  • 29.1. Africa Hematocrit Test Devices Market Overview
  • 29.2. Africa Hematocrit Test Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Hematocrit Test Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Hematocrit Test Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hematocrit Test Devices Market Competitive Landscape And Company Profiles

  • 30.1. Hematocrit Test Devices Market Competitive Landscape
  • 30.2. Hematocrit Test Devices Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Hematocrit Test Devices Market Other Major And Innovative Companies

  • 31.1. Danaher Corporation
  • 31.2. Siemens Healthcare GmbH
  • 31.3. Becton, Dickinson and Company (BD)
  • 31.4. Terumo Corporation
  • 31.5. Beckman Coulter Inc.
  • 31.6. Mindray Medical International Limited
  • 31.7. bioMerieux SA
  • 31.8. Sysmex Corporation
  • 31.9. Horiba Ltd.
  • 31.10. Nihon Kohden Corporation
  • 31.11. Erba Mannheim
  • 31.12. Heska Corporation
  • 31.13. EKF Diagnostics Holding Plc.
  • 31.14. Nova Biomedical Corporation
  • 31.15. Boule Diagnostics AB

32. Global Hematocrit Test Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hematocrit Test Devices Market

34. Recent Developments In The Hematocrit Test Devices Market

35. Hematocrit Test Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Hematocrit Test Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Hematocrit Test Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Hematocrit Test Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer